Brothers Life Sciences Capital (gp) Llc Baker is Director & 10% at GENOMIC HEALTH INC (GHDX). They have made 58 open-market trades across 12 companies since 2006, most recently 2012-03-05.
CIK 0001307729
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
49 open-market purchases totalling $313.8M since 2006, against 9 sales. Across 34 scored buys the stock is down 3.1% at ninety days, and 3.3 points behind the S&P over the same stretch.
34 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -16.9% | -3.1% | -3.1% |
| Alpha | -11.1% | -3.3% | -3.3% |
| Scored | 34 | 34 | 34 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | BUY | 2012-03-01 | 2012-03-05 | $29.81 | $7.8M | -10.0% | -1.8% | -1.8% |
| GHDX | BUY | 2012-02-14 | 2012-02-16 | $29.36 | $8.0M | -10.0% | -1.8% | -1.8% |
| PCYC | BUY | 2012-01-19 | 2012-01-23 | $16.55 | $7.4M | N/A | N/A | N/A |
| INCY | BUY | 2011-12-05 | 2011-12-07 | $13.75 | $21.4M | -26.4% | -3.0% | -3.0% |
| GHDX | BUY | 2011-12-02 | 2011-12-05 | $28.12 | $3.3M | -10.0% | -1.8% | -1.8% |
| INCY | BUY | 2011-11-29 | 2011-12-01 | $13.13 | $31.6M | -26.4% | -3.0% | -3.0% |
| PCYC | BUY | 2011-11-21 | 2011-11-23 | $12.57 | $3.0M | N/A | N/A | N/A |
| SGEN | BUY | 2011-08-23 | 2011-08-25 | $15.38 | $17.9M | -17.1% | -4.5% | -4.5% |
| VPHM | BUY | 2011-08-10 | 2011-08-12 | $16.59 | $4.0M | N/A | N/A | N/A |
| AUXL | BUY | 2011-03-29 | 2011-03-31 | $21.99 | $7.3M | N/A | N/A | N/A |
| GHDX | BUY | 2011-03-09 | 2011-03-11 | $26.03 | $1.8M | -10.0% | -1.8% | -1.8% |
| AUXL | BUY | 2011-03-08 | 2011-03-10 | $22.90 | $22.6M | N/A | N/A | N/A |
| GHDX | BUY | 2011-03-04 | 2011-03-08 | $25.06 | $8.8M | -10.0% | -1.8% | -1.8% |
| GHDX | BUY | 2011-02-23 | 2011-02-25 | $23.39 | $3.7M | -10.0% | -1.8% | -1.8% |
| RDEA | BUY | 2011-01-20 | 2011-01-24 | $26.00 | $9.2M | N/A | N/A | N/A |
| GHDX | BUY | 2010-08-16 | 2010-08-18 | $14.99 | $288K | -10.0% | -1.8% | -1.8% |
| SGEN | BUY | 2010-06-07 | 2010-06-09 | $11.93 | $7.1M | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2010-05-25 | 2010-05-27 | $11.95 | $65K | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2010-05-03 | 2010-05-05 | $12.79 | $7.2M | -17.1% | -4.5% | -4.5% |
| ADLR | BUY | 2010-04-29 | 2010-05-03 | $1.98 | $79K | N/A | N/A | N/A |
| VPHM | BUY | 2010-04-28 | 2010-04-30 | $12.87 | $25.0M | N/A | N/A | N/A |
| ADLR | BUY | 2010-04-26 | 2010-04-28 | $1.98 | $593K | N/A | N/A | N/A |
| AUXL | BUY | 2010-03-09 | 2010-03-11 | $32.47 | $4.2M | N/A | N/A | N/A |
| GHDX | BUY | 2010-02-08 | 2010-02-10 | $17.01 | $5.8M | -10.0% | -1.8% | -1.8% |
| GHDX | BUY | 2009-08-13 | 2009-08-17 | $19.98 | $1.3M | -10.0% | -1.8% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| TRMS | 1,252,625 | — |
| ADLR | 6,669,338 | — |
| VPHM | 7,918,477 | — |
| ALTH | 6,498,682 | — |
| AUXL | 6,023,365 | — |
| IBPI | 1,000,982 | — |
| IDP | 418,030 | — |
| Total | $5.0B |
Shares reported on the most recent Form 4, priced at the 2012-03-05 close. 9 holdings could not be priced and are excluded from the total.